Neuroprotective role of tripchlorolide on inflammatory neurotoxicity induced by lipopolysaccharide-activated microglia

Biochemical Pharmacology

Volumn 76, Issue 3, 2008, Pages 362-372

  Pan, Xiao dong ^a,b   Chen, Xiao chun ^a,b   Zhu, Yuan gui ^a,b   Zhang, Jing ^a   Huang, Tian wen ^a,b   Chen, Li min ^a   Ye, Qin yong ^a,b   Huang, Hua pin ^a,b  

^a BEIJING HOSPITAL   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Lipopolysaccharide; Microglia; Neuroinflammation; Neurons; Tripchlorolide

Indexed keywords

CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; NEUROPROTECTIVE AGENT; NITRIC OXIDE; PROSTAGLANDIN E2; SUPEROXIDE; TRIPCHLOROLIDE; TRIPTERYGIUM WILFORDII EXTRACT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BRAIN CELL; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG STRUCTURE; MICROGLIA; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN TARGETING;

ANIMALS; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CELL LINE; CELL SURVIVAL; CULTURE MEDIA, CONDITIONED; CYCLOOXYGENASE 2; DINOPROSTONE; DITERPENES; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MICE; MICROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXICITY SYNDROMES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHENANTHRENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 46649088909     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2008.05.018     Document Type: Article

References (52)

1. Giulian D., Haverkamp L.J., Li J., Karshin W.L., Yu J., Tom D., et al. Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain. Neurochem Int 27 (1995) 119-137
2. Walker D.G., and Lue L.F. Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases. J Neurosci Res 81 (2005) 412-425
3. McGeer P.L., Kawamata T., Walker D.G., Akiyama H., Tooyama I., and McGeer E.G. Microglia in degenerative neurological disease. Glia 7 (1993) 84-92
4. McGeer P.L., and McGeer E.G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev 21 (1995) 195-218
5. Rich J.B., Rasmusson D.X., Folstein M.F., Carson K.A., Kawas C., and Brandt J. Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 45 (1995) 51-55
6. Schenk D. Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning. Nat Rev Neurosci 3 (2002) 824-828
7. Tao X., Cush J.J., Garret M., and Lipsky P.E. A phase I study of ethyl acetate extract of the Chinese antirheumatic herb Tripterygium wilfordii Hook F in rheumatoid arthritis. J Rheumatol 28 (2001) 2160-2167
8. Tao X.L. [Mechanism of treating rheumatoid arthritis with Tripterygium wilfordii hook. II. Effect on PGE2 secretion]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 11 (1989) 36-40
9. Zhou H.F., Liu X.Y., Niu D.B., Li F.Q., He Q.H., and Wang X.M. Triptolide protects dopaminergic neurons from inflammation-mediated damage induced by lipopolysaccharide intranigral injection. Neurobiol Dis 18 (2005) 441-449
10. Xue B., Jiao J., Zhang L., Li K.R., Gong Y.T., Xie J.X., et al. Triptolide upregulates NGF synthesis in rat astrocyte cultures. Neurochem Res 32 (2007) 1113-1119
11. Yu D.Q., Zhang D.M., Wang H.B., and Liang X.T. [Structure modification of triptolide, a diterpenoid from Tripterygium wilfordii]. Yao Xue Xue Bao 27 (1992) 830-836
12. Li F.Q., Cheng X.X., Liang X.B., Wang X.H., Xue B., He Q.H., et al. Neurotrophic and neuroprotective effects of tripchlorolide, an extract of Chinese herb Tripterygium wilfordii Hook F, on dopaminergic neurons. Exp Neurol 179 (2003) 28-37
13. Hong Z., Wang G., Gu J., Pan J., Bai L., Zhang S., et al. Tripchlorolide protects against MPTP-induced neurotoxicity in C57BL/6 mice. Eur J Neurosci 26 (2007) 1500-1508
14. Chao C.C., and Hu S. Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures. Dev Neurosci 16 (1994) 172-179
15. Le W., Rowe D., Xie W., Ortiz I., He Y., and Appel S.H. Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease. J Neurosci 21 (2001) 8447-8455
16. Giulian D., and Baker T.J. Characterization of ameboid microglia isolated from developing mammalian brain. J Neurosci 6 (1986) 2163-2178
17. Watters J.J., Sommer J.A., Pfeiffer Z.A., Prabhu U., Guerra A.N., and Bertics P.J. A differential role for the mitogen-activated protein kinases in lipopolysaccharide signaling: the MEK/ERK pathway is not essential for nitric oxide and interleukin 1beta production. J Biol Chem 277 (2002) 9077-9087
18. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., and Tannenbaum S.R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126 (1982) 131-138
19. Bruce-Keller A.J., Keeling J.L., Keller J.N., Huang F.F., Camondola S., and Mattson M.P. Antiinflammatory effects of estrogen on microglial activation. Endocrinology 141 (2000) 3646-3656
20. Choi H.S., Kim J.W., Cha Y.N., and Kim C. A quantitative nitroblue tetrazolium assay for determining intracellular superoxide anion production in phagocytic cells. J Immunoassay Immunochem 27 (2006) 31-44
21. Huang Q., Wu L.J., Tashiro S., Onodera S., and Ikejima T. Elevated levels of DNA repair enzymes and antioxidative enzymes by (+)-catechin in murine microglia cells after oxidative stress. J Asian Nat Prod Res 8 (2006) 61-71
22. Zhu Y.G., Chen X.C., Chen Z.Z., Zeng Y.Q., Shi G.B., Su Y.H., et al. Curcumin protects mitochondria from oxidative damage and attenuates apoptosis in cortical neurons. Acta Pharmacol Sin 25 (2004) 1606-1612
23. Pinteaux E., Rothwell N.J., and Boutin H. Neuroprotective actions of endogenous interleukin-1 receptor antagonist (IL-1ra) are mediated by glia. Glia 53 (2006) 551-556
24. Taylor D.L., Jones F., Kubota E.S., and Pocock J.M. Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor alpha-induced neurotoxicity in concert with microglial-derived Fas ligand. J Neurosci 25 (2005) 2952-2964
25. Wen W., Sanelli T., Ge W., Strong W., and Strong M.J. Activated microglial supernatant induced motor neuron cytotoxicity is associated with upregulation of the TNFR1 receptor. Neurosci Res 55 (2006) 87-95
26. Min K.J., Jou I., and Joe E. Plasminogen-induced IL-1beta and TNF-alpha production in microglia is regulated by reactive oxygen species. Biochem Biophys Res Commun 312 (2003) 969-974
27. Blasi E., Barluzzi R., Bocchini V., Mazzolla R., and Bistoni F. Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J Neuroimmunol 27 (1990) 229-237
28. Bocchini V., Mazzolla R., Barluzzi R., Blasi E., Sick P., and Kettenmann H. An immortalized cell line expresses properties of activated microglial cells. J Neurosci Res 31 (1992) 616-621
29. Mirzoeva S., Koppal T., Petrova T.V., Lukas T.J., Watterson D.M., and Van Eldik L.J. Screening in a cell-based assay for inhibitors of microglial nitric oxide production reveals calmodulin-regulated protein kinases as potential drug discovery targets. Brain Res 844 (1999) 126-134
30. Flavin M.P., Coughlin K., and Ho L.T. Soluble macrophage factors trigger apoptosis in cultured hippocampal neurons. Neuroscience 80 (1997) 437-448
31. Castano A., Herrera A.J., Cano J., and Machado A. Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system. J Neurochem 70 (1998) 1584-1592
32. Gayle D.A., Ling Z., Tong C., Landers T., Lipton J.W., and Carvey P.M. Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-alpha, interleukin-1beta, and nitric oxide. Brain Res Dev Brain Res 133 (2002) 27-35
33. Gelbard H.A., Dzenko K.A., DiLoreto D., del Cerro C., del Cerro M., and Epstein L.G. Neurotoxic effects of tumor necrosis factor alpha in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: implications for AIDS neuropathogenesis. Dev Neurosci 15 (1993) 417-422
34. Combs C.K., Karlo J.C., Kao S.C., and Landreth G.E. Beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J Neurosci 21 (2001) 1179-1188
35. Schubert P., and Rudolphi K. Interfering with the pathologic activation of microglial cells and astrocytes in dementia. Alzheimer Dis Assoc Disord 12 Suppl. 2 (1998) S21-S28
36. Iravani M.M., Kashefi K., Mander P., Rose S., and Jenner P. Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration. Neuroscience 110 (2002) 49-58
37. Lee P., Son D., Lee J., Kim Y.S., Kim H., and Kim S.Y. Excessive production of nitric oxide induces the neuronal cell death in lipopolysaccharide-treated rat hippocampal slice culture. Neurosci Lett 349 (2003) 33-36
38. Jeohn G.H., Kim W.G., and Hong J.S. Time dependency of the action of nitric oxide in lipopolysaccharide-interferon-gamma-induced neuronal cell death in murine primary neuron-glia co-cultures. Brain Res 880 (2000) 173-177
39. Munch G., Gasic-Milenkovic J., Dukic-Stefanovic S., Kuhla B., Heinrich K., Riederer P., et al. Microglial activation induces cell death, inhibits neurite outgrowth and causes neurite retraction of differentiated neuroblastoma cells. Exp Brain Res 150 (2003) 1-8
40. Bal-Price A., and Brown G.C. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J Neurosci 21 (2001) 6480-6491
41. Minghetti L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol 63 (2004) 901-910
42. Kawano T., Anrather J., Zhou P., Park L., Wang G., Frys K.A., et al. Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity. Nat Med 12 (2006) 225-229
43. Zhou H.F., Niu D.B., Xue B., Li F.Q., Liu X.Y., He Q.H., et al. Triptolide inhibits TNF-alpha, IL-1 beta and NO production in primary microglial cultures. Neuroreport 14 (2003) 1091-1095
44. Dai Y.Q., Jin D.Z., Zhu X.Z., and Lei D.L. Triptolide inhibits COX-2 expression via NF-kappa B pathway in astrocytes. Neurosci Res 55 (2006) 154-160
45. Qiu D., Zhao G., Aoki Y., Shi L., Uyei A., Nazarian S., et al. Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation. J Biol Chem 274 (1999) 13443-13450
46. Li F.Q., Lu X.Z., Liang X.B., Zhou H.F., Xue B., Liu X.Y., et al. Triptolide, a Chinese herbal extract, protects dopaminergic neurons from inflammation-mediated damage through inhibition of microglial activation. J Neuroimmunol 148 (2004) 24-31
47. Karin M., Yamamoto Y., and Wang Q.M. The IKK NF-kappa B system: a treasure trove for drug development. Nat Rev Drug Discov 3 (2004) 17-26
48. Haddad J.J., Safieh-Garabedian B., Saade N.E., Kanaan S.A., and Land S.C. Chemioxyexcitation (delta pO2/ROS)-dependent release of IL-1 beta. IL-6 and TNF-alpha: evidence of cytokines as oxygen-sensitive mediators in the alveolar epithelium. Cytokine 13 (2001) 138-147
49. Haddad J.J. Recombinant human interleukin (IL)-1 beta-mediated regulation of hypoxia-inducible factor-1 alpha (HIF-1 alpha) stabilization, nuclear translocation and activation requires an antioxidant/reactive oxygen species (ROS)-sensitive mechanism. Eur Cytokine Netw 13 (2002) 250-260
50. Philipp S., Cui L., Ludolph B., Kelm M., Schulz R., Cohen M.V., et al. Desferoxamine and ethyl-3,4-dihydroxybenzoate protect myocardium by activating NOS and generating mitochondrial ROS. Am J Physiol 290 (2006) H450-H457
51. Hensley K., Maidt M.L., Yu Z., Sang H., Markesbery W.R., and Floyd R.A. Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J Neurosci 18 (1998) 8126-8132
52. Tarkowski E., Blennow K., Wallin A., and Tarkowski A. Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia. J Clin Immunol 19 (1999) 223-230